801316-10-9 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-(3-carbamoyl-4-(3-methoxyphenylamino)-8-methylquinolin-6-ylthio)benzoate is used as a potential pharmaceutical agent for its possible interactions with biological systems. Its complex structure may allow it to target specific receptors or enzymes, making it a candidate for the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, methyl 3-(3-carbamoyl-4-(3-methoxyphenylamino)-8-methylquinolin-6-ylthio)benzoate could be utilized as a component in the development of new pesticides or herbicides. Its chemical properties might enable it to effectively control pests or weeds while minimizing environmental impact.
Used in Materials Science:
Methyl 3-(3-carbamoyl-4-(3-methoxyphenylamino)-8-methylquinolin-6-ylthio)benzoate may also find applications in materials science, potentially serving as a component in the synthesis of new materials with unique properties. Its ability to interact with other molecules could contribute to the creation of advanced materials with specific characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 801316-10-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,0,1,3,1 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 801316-10:
(8*8)+(7*0)+(6*1)+(5*3)+(4*1)+(3*6)+(2*1)+(1*0)=109
109 % 10 = 9
So 801316-10-9 is a valid CAS Registry Number.
801316-10-9Relevant academic research and scientific papers
Repurposing human PDE4 inhibitors for neglected tropical diseases. evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of pdeb1 of trypanosoma brucei
Ochiana, Stefan O.,Bland, Nicholas D.,Settimo, Luca,Campbell, Robert K.,Pollastri, Michael P.
, p. 549 - 564 (2015/04/22)
Cyclic nucleotide phosphodiesterases (PDEs) have been identified as important enzyme targets for drug development in both humans and Trypanosoma brucei, the causative agent of human African trypanosomiasis. With this in mind, we recently reported the prof
QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
-
Page 169-170, (2008/06/13)
There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
